FDA vs CE for Clinics (2025): A One-Page Guide to Procurement Compliance

The short answer: The U.S. market requires FDA clearance or authorization for a medical device to be legally marketed; the EU’s CE mark indicates conformity with MDR requirements—these are two separate legal pathways and are not interchangeable.

As a clinic owner or procurement manager, ensuring every piece of medical equipment is compliant is fundamental to patient safety and mitigating legal risk. However, when sourcing devices from global suppliers, the differences between the two main regulatory systems, FDA and CE, can be confusing. This guide provides a clear, actionable framework for verifying compliance in the U.S., EU, UK, Canada, and Australia, with a special focus on key regulatory changes for 2025–2026 to help you perform due diligence efficiently.

In the United States context, an “FDA Registration and Listing” only indicates that a facility and its devices are registered with the agency; it does not mean the device is approved, cleared, or authorized for sale. Always verify a device’s specific marketing authorization status before procurement. For more background, you can refer to our buyer’s guide on FDA-cleared devices.

Core Differences at a Glance: FDA vs. CE

Verifiable Facts for Your Reference:

• [2025-10-01] All De Novo requests for medical devices must be submitted using the eSTAR (electronic Submission Template). (Source: FDA)
• [2026-02-02] The new QMSR (Quality Management System Regulation) will become effective, replacing the current QSR (21 CFR 820). (Source: FDA)

The Youlumi Perspective: Our Compliance Playbook

We understand that regulatory transparency is the only way to build trust. Youlumi is committed to providing clinics worldwide with clear, verifiable compliance support to ensure every purchase you make is backed by evidence.

Our Commitment to Transparency

• Verifiable Evidence Chain: For every device sold in a specific market, we provide a complete compliance package. This includes, but is not limited to, the applicable regulatory pathway declaration, Declaration of Conformity (DoC), Notified Body (NB) certificate (if applicable), a direct link or number for official registries (like EUDAMED or Devices@FDA), user manuals, and proof of a quality management system.
• Procurement & Onboarding: We recommend clinics use an inquiry template during initial discussions to request specific license numbers and evidence files. Your contract should include clauses on “notification of regulatory changes,” “replacement/return policies,” and “delivery milestones” to protect your interests. Need a template or consultation? Feel free to contact us anytime.
• Ethical Language: We strictly adhere to regulatory guidelines, using terms like “supports” or “helps” for device efficacy and avoiding ambiguous or misleading phrases such as “FDA certified.” Visit our blog for more in-depth articles on compliant marketing.

United States (FDA)｜A 4-Step Verification Method for Clinics

Key Takeaway: In the U.S., the core of clinic procurement is verifying that a device has received FDA marketing authorization, not just that it’s “registered.” First, identify its regulatory pathway (510(k), De Novo, PMA, or Exempt), then verify it in the official database, and finally, be aware of how upcoming eSTAR and QMSR requirements will impact documentation in 2025–2026.

Step 1: Confirm the Device Classification and Pathway

Medical devices are classified by risk into Class I, II, and III. Most Class II devices require a 510(k) submission to demonstrate “substantial equivalence” to a legally marketed device. Novel, low-to-moderate risk devices follow the De Novo pathway, while high-risk Class III devices require the most stringent PMA (Premarket Approval). Some Class I devices may be Exempt from premarket notification. You should first ask the supplier to confirm their device’s classification and regulatory pathway.

Step 2: Verify the Marketing Authorization

This is the most critical step. The supplier must provide a specific submission number (e.g., Kxxxxxx, DENxxxxxx, Pxxxxxx). You can then visit the FDA Medical Device Databases index page to search for the device in the appropriate database.

Step 3: Perform Auxiliary Checks (UDI and Registration & Listing)

• UDI (Unique Device Identifier): Helps track a device through its lifecycle, but its presence does not equal marketing authorization.
• Registration & Listing: This only means the manufacturer and its devices have been entered into the FDA’s registry.

Verifiable Fact: The FDA explicitly states that Registration & Listing ≠ Approval, Clearance, or Authorization. Clinics should be wary of any supplier promoting a device based solely on its “FDA Registered” status. (Source: FDA Consumer Guidance)

Step 4: Understand the 2025–2026 Impact of eSTAR and QMSR

• eSTAR for De Novo (Mandatory Oct 1, 2025): From this date, all De Novo requests must be submitted via the eSTAR template. This standardizes submission formats, making reviews more efficient.
• QMSR Becomes Effective (Feb 2, 2026): The new QMSR aligns FDA’s quality system requirements more closely with the international standard ISO 13485. Suppliers will need to provide documentation compliant with this new regulation.

European Union (MDR)｜A 4-Step Verification Method for Clinics

Key Takeaway: In the EU, the CE mark is the passport to the market, certifying that a device complies with the Medical Device Regulation (MDR 2017/745). Clinics should proactively request and verify the Declaration of Conformity (DoC), Notified Body (NB) certificate (if applicable), and UDI/EUDAMED entry.

Step 1: Understand the CE Mark and MDR Obligations

The CE mark signifies that the manufacturer has declared, in accordance with Article 20 of the MDR 2017/745, that its product meets all applicable safety and performance requirements.

Step 2: Request the Core Document Package

• Declaration of Conformity (DoC): A legal document signed by the manufacturer declaring the device conforms to the MDR.
• Notified Body (NB) Certificate: For sterile/measuring/reusable surgical Class I devices, and all Class IIa, IIb, and III devices, an NB must audit the device and issue a certificate.
• UDI/EUDAMED Entry: The supplier should be able to provide the device’s UDI-DI for you to look up in the EUDAMED database.

Step 3: Verify in EUDAMED

EUDAMED (European Database on Medical Devices) is the official EU registry. While its modules are being rolled out in phases, it can already be used to look up registered devices and economic operators.

Verifiable Fact: EUDAMED is the official database for the EU’s MDR/IVDR. Clinics can and should ask suppliers for a device’s UDI to cross-verify its registration status.

Step 4: Monitor the Gradual EUDAMED Rollout

As more EUDAMED modules become mandatory, the completeness and authority of its data will increase. Clinics should make a habit of using it and treat it as the central hub for future compliance checks in the EU.

Verification in Other Key Markets

United Kingdom (UKCA/CE in GB/NI)｜A 3-Step Check

Key Takeaway: Post-Brexit, Great Britain (GB: England, Wales, Scotland) uses the UKCA mark. Northern Ireland (NI) follows EU rules and accepts the CE mark or the UKNI mark.

1. Confirm the Market: Is the device for use in GB or NI?
2. Check the Mark: Look for the UKCA mark for GB or the CE/UKNI mark for NI.
3. Query the Registry: Use the MHRA’s public access database to verify registration.

Canada (Health Canada)｜A 3-Step Check

Key Takeaway: In Canada, Class II, III, and IV medical devices must have a Medical Device Licence (MDL) issued by Health Canada to be sold.

1. Request the MDL Number: Ask the supplier for the 6-digit license number.
2. Search MDALL: Visit the official Medical Devices Active Licence Listing (MDALL).
3. Verify Information: Enter the number or company/device name to confirm the details match.

Australia (TGA/ARTG)｜A 3-Step Check

Key Takeaway: All medical devices sold in Australia must be included in the Australian Register of Therapeutic Goods (ARTG).

1. Request the ARTG ID: The supplier must provide this number.
2. Search the ARTG database: Access the public ARTG database via the TGA website.
3. Check the Details: Confirm the device information, manufacturer, and Australian Sponsor are correct.

2025–2026 Key Compliance Timeline & Action Items

Clinic Procurement Compliance Checklist

Common Misconceptions & Counter-Scripts

• Misconception 1: “We are FDA Registered/Certified, so we can sell it.”

  Counter-Script: “Thank you for the information. ‘Registration’ is not the same as ‘authorization.’ To proceed, please provide the device’s 510(k), De Novo, or PMA marketing authorization number and the corresponding link to its entry in the FDA’s public database.”

• Misconception 2: “It has a CE mark, so it can be used in a U.S. clinic.”

  Counter-Script: “The CE mark is for the EU market. Under FDA regulations, medical devices marketed in the U.S. require specific FDA authorization. Does this device have a separate FDA clearance or approval number?”

• Misconception 3: “It has a UDI, so it must be compliant.”

  Counter-Script: “The UDI is an important identifier for traceability, but it is not proof of marketing authorization. Please provide the device’s marketing authorization documents and number as well.”

Case Study: Verifying a Red Light Therapy Device

Imagine you plan to procure a red light therapy device for a specific clinical indication:

1. For the U.S. Market: You should request the supplier’s 510(k) number (e.g., K21xxxx). You would then visit the FDA’s 510(k) database, enter the number, and verify that the applicant, device name, classification (usually Class II), and, most importantly, the “Indications for Use” statement match your clinical needs. Save a screenshot of this page for your procurement records.
2. For the EU Market: The supplier must provide a signed Declaration of Conformity (DoC) stating compliance with MDR (EU) 2017/745. If it’s a Class IIa or IIb device, they must also provide a valid certificate from a Notified Body (e.g., TÜV SÜD, BSI). You should verify the certificate and request the UDI-DI to look it up in EUDAMED.
3. For UK/CA/AU Markets:
   • UK: Request proof of MHRA registration and a UKCA Declaration of Conformity.
   • Canada: Request the valid MDL number from the MDALL database.
   • Australia: Request the registration number from the ARTG database.

Disclaimer: The information provided in this article is for educational purposes only and does not constitute legal, regulatory, or medical advice. Clinics should consult with an independent legal advisor or compliance expert for guidance on their specific situations.

Frequently Asked Questions (FAQ)

Q1: Can a device with only a CE mark be legally purchased and used in a U.S. clinic?
A: No. The CE mark is a market authorization for the European Union and is not recognized by the FDA. In the U.S., any medical device intended to diagnose, treat, or prevent a disease must receive FDA marketing authorization (e.g., 510(k) clearance, De Novo authorization, or PMA approval). Procuring and using a CE-only device in a U.S. clinic carries significant legal and patient safety risks.

Q2: In the EU, what does the CE mark really mean, and what documents should a clinic request for verification?
A: The CE mark indicates the manufacturer’s declaration that their product complies with all applicable requirements of the EU’s Medical Device Regulation (MDR 2017/745). A clinic should request at least three core documents for verification: 1) the signed Declaration of Conformity (DoC); 2) if the device is a higher risk class than non-sterile/non-measuring Class I, a certificate issued by a Notified Body (NB); and 3) the device’s UDI-DI for lookup in the EUDAMED database.

Q3: What is the simplest 3-step verification method for the UK, Canadian, and Australian markets?
A:

• UK: Confirm the market (GB vs. NI) → Check the mark (UKCA vs. CE) → Search the MHRA database.
• Canada: Request the MDL number → Search the MDALL database → Verify the information.
• Australia: Request the ARTG ID → Search the TGA database → Check the Sponsor and device details.

Q4: How does the new QMSR (effective Feb 2, 2026) practically affect our clinic?
A: The QMSR aligns the FDA’s quality system requirements more closely with the international standard ISO 13485. For clinics, this means your suppliers (especially for the U.S. market) must update their quality management processes, which should lead to more consistent and higher-quality products. In procurement contracts after 2026, you can and should require proof of QMSR compliance.

Q5: How can I identify and counter misleading claims like “FDA Registered”?
A: Go straight to requesting verifiable evidence. A standard counter-script is: “According to the FDA’s official guidance, ‘registration’ does not denote approval or clearance. For compliance purposes, please provide the 510(k), De Novo, or PMA authorization number for this device so we can verify it on the FDA’s website.”

Q6: If I source a device from the EU for use in the U.S., what contract clauses are critical?
A: This cross-border procurement is high-risk, as the device may lack FDA authorization. If the supplier claims it has it, the contract must explicitly state: 1) the specific FDA marketing authorization number (e.g., Kxxxxxx); 2) a warranty that this number is authentic and a direct link to the FDA database entry; and 3) a nullification and indemnity clause stating that if the authorization is revoked or found to be invalid, the supplier assumes full liability, including but not limited to device recall, refunds, and compensation for any damages incurred by the clinic.

Q7: What compliance documentation does Youlumi provide for its red light therapy devices in different markets?
A: For every market we serve, we provide a complete and traceable compliance package. For example, for products sold in the U.S., we provide the 510(k) clearance letter and database link. For products sold in the EU, we provide the CE Declaration of Conformity and relevant certificates. We encourage all prospective clients to contact our compliance team before purchasing to receive the detailed documentation specific to your region.

Last updated: October 14, 2025